MedTrace Logo

NHS Staff Digital Wellbeing Via AirEmail

NCT06111001 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2023-11-01

No results posted yet for this study

Summary

The goal of this "digital health intervention" study is to test a novel email management tool called "AirEmail" (version 1, or v1) for its impact on improving key aspects of healthcare email management.

The main questions it aims to answer are:

* What are the effects of technostress in staff employed by the National Health Service (NHS)?
* Can the AirEmail digital tool improve email productivity?
* Can the AirEmail digital tool improve participant digital wellbeing?

Participants will use AirEmail for a period of 4 weeks as part of their routine management of healthcare email. This active use period will be preceded and followed by 2 weeks of an "observational mode" in which email use data is collected.

Researchers will compare participants in the active study group with participants in the contemporary observational group to see if the volume and patterns of email communications have been affected by external factors or AirEmail use.

Conditions

  • Communication Research
  • Technostress
  • Work Related Stress
  • Burnout, Professional
  • Well-Being, Psychological

Interventions

OTHER

Email use data collection

Participants will initiate the AirEmail v1 Digital Tool. Non-identifiable email use data will be collected.

OTHER

AirEmail Tips and Tricks training

Participants will watch the "AirEmail Tips and Tricks" training videos ahead of using the AirEmail v1 Digital Tool

OTHER

AirEmail v1 Digital Tool use

Participants will use the AirEmail v1 Digital Tool features as part of their routine email management in NHSmail, the NHS's Microsoft 365 Outlook platform.

Sponsors & Collaborators

  • AirEmail Holdings Limited

    lead INDUSTRY

Principal Investigators

  • Jay Mehta, Dr · AirEmail Holdings Limited, Royal Free London NHS Foundation Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06111001 on ClinicalTrials.gov